SLP
BMY icon

Storen Legacy Partners’s Bristol-Myers Squibb BMY Stock Holding History

Storen Legacy Partners’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$372K Sell
6,451
-485
-7% -$27.8K 0.1% 81
2026
Q1 		$421K Buy
6,936
+2
+0% +$117 0.13% 70
2025
Q4 		$374K Buy
+6,934
New +$334K 0.12% 50

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Storen Legacy Partners's BMY Position: Q2 2026 in Review

Storen Legacy Partners reduced its Bristol-Myers Squibb (BMY) stake by 7% in Q2 2026, selling an estimated $27.8K and leaving 6,451 shares worth $372K. The position accounts for 0.1% of the portfolio, ranked #81.

Storen Legacy Partners first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $421K in Q1 2026. 2,502 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Storen Legacy Partners held 6,451 shares of Bristol-Myers Squibb worth $372K as of Q2 2026.
  • Storen Legacy Partners sold 485 Bristol-Myers Squibb shares in Q2 2026, an estimated $27.8K.
  • Bristol-Myers Squibb made up 0.1% of Storen Legacy Partners's portfolio in Q2 2026, its #81 holding.
  • Storen Legacy Partners first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
  • Storen Legacy Partners's Bristol-Myers Squibb position peaked at $421K in Q1 2026.
  • 2,502 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Storen Legacy Partners's 13F filing for Q2 2026, filed 17 Jul 2026.